Parents and advocates fear legal challenges could delay production and sales of medical cannabis

Some advocates and parents of patients of people with debilitating diseases now fear that recent lawsuits will delay the cultivation and sale of the drug in the state.

The Georgia Access to Medical Cannabis Commission recently granted licenses to Trulieve and Botanical Sciences to begin selling low-THC oil to registered patients who suffer from severe seizures, Parkinson’s disease and cancer in last phase.

“We are very excited that patients will soon be able to purchase this oil here in Georgia,” said Shannon Cloud, whose daughter Elena lives with Dravet syndrome, a severe form of epilepsy that can lead to developmental delays.

But that left at least nine companies that didn’t get licenses.

They sued, claiming the process was unfair. The Superior Court ordered the Medical Cannabis Commission to stop issuing licenses until the cases are resolved. This could delay the eventual production and sale of medical cannabis in Georgia.

“It could absolutely slow things down. It’s just a frustrating process,” Cloud said. “Parents and patients had to work hard to find the oil, often breaking state and federal laws to get the oil here in Georgia.”

FOX 5 Atlanta called the Medical Cannabis Commission. We are waiting for an answer.

For now, just two companies will be able to serve more than 24,000 patients and nearly 18,000 caregivers statewide.

“If there are further delays, it just means these people have to wait more months and not get the relief they need,” Cloud said.

Patients hope that two businesses can accommodate all those who need help the most.

Comments are closed.